Избирательная токсичность. Физико-химические основы терапии Том 2 - Альберт А.
ISBN 412-26010-7
Скачать (прямая ссылка):
Plaut G. — In: Pteridine Chemistry/Eds. W. Pfleiderer, E. Taylor, Oxford: Per-
gamon Press, 1964, p. 443. Poate H. — Lancet, 1944, ii, p. 238. Med. J. Austral., 1944, i, p. 242. Poiesz B., Seal G., Loeb L. — Proc. Natl. Acad. Sci., U.S.A., 1974, vol. 71, p. 4892.
Poirier L., Miller I., Miller E., Sato K- — Cancer Res., 1967, vol. 27, p. 1600. Pomeranz B., Chiu D. — Life Sci., 1976, vol. 19, p. 1757.
Pope L., Reich K., Graham D., Sigman D. — S. Biol. Chem., 1982, vol. 257, p. 12121.
PopoviciU v. —Studia Biophys. (Berlin), 1978, Bd 69, S. 75. Portoghese P., Mikhail A., Kupferberg H.—i. Med. Chem., 1968, vol. 11, p. 219. Powell P., Cline G., Reid C., Szaniszlo P. — Nature, Lond., 1980, vol. 287, p. 833. Prakash N., Schechter P., Mamont P. et al. — Life Sci., 1980, vol. 26, p. 181. Pressman B., Guzman N. — Ann. N.Y. Acad. Sci., 1974, vol. 227, p. 380. Prestegard 1., Chan S. — J. Amer. Chem. Soc., 1970, vol. 92, p. 4440. Preston H., Steward J. — Chem. Commun. Chem. Soc., Lond., 1970, p. 1142. Prichard B., Gillam P.— Brit. Med. J., 1964, ii, p. 725. Pringle M., Brown K., Miller K.— Molec. Pharmacol., 1981, vol. 19, p. 49. Proctor P., Gensmantel N., Page M. — i. Chem. Soc., Perkin 11, 1982, p. 1185. Propping P. — Rev. Physiol. Biochem. Pharmacol., 1978, vol. 82, p. 123. Pullman A., Pullman B. Cancerisation par Ies Substances chimiques et Structures moleculaires.— Paris: Masson, 1955. Purcell W., Bass G., Glayton 1. Strategy of Drug Design. — New York: Wiley-Interscience, 1973.
Purchase /., Longstaff E., Ashby J. et al. — Nature, Lond., 1976, vol. 264, p. 624.
Putnam F., Neurath H. — J. Amer. Chem. Soc., 1944, vol. 66, p. 1992.
Quastel J., Wooldridge 117.—Biochem. J., 1927, vol. 21, p. 1224.
Raa 3., Gokseyr J. — Physiol. Plantarum, 1966, vol. 19, p. 840. " ¦
Rabenstein D„ Anvarhusein A. — Anal. Chem., 1982, vol. 54, p. 526.
Racker E., Krimsky L — J. Exper Med., 1947, vol. 85, p. 715.
Rahwan R., Witiak D. (eds) Calcium Regulation by Calcium Antagonists. —
Washington: American Chemical Society, 1982. Rajan K., Davis 3., Colburn R. — l. Neurochem., 1974 vol. 22, p. 137. Randall L. — Dis. Nerv. Syst., 1961, vol. 22, p. 7. Randic M. — i. Chem. Phys., 1974, vol. 60, p. 3920. Rando R. — Biochemistry, 1974, vol. 13, p. 3859.
Rappaport C., Howze G. — Proc. Soc. Exper. Biol. Med., 1966 vol. 121, pp 1010, 1016.
Raventos Л— Quart. J. Exper. Physiol., 1937, vol. 26, p. 361. Redl G., Cramer R., Berkoff C.—Chem. Soc. Rev. Lond., 1974, vol. 3, p. 273. Redmond D., Kleber H. — Psychiat. Res., 1980, vol. 2, p. 37. Rekker R. The Hydrophobic Fragmental Constant. — Amsterdam: Elsevier, 1977. Rekker R., De Kort H. — Eur. J. Med. Chem., 1979, vol. 14, p. 479. Reynolds J. (ed.) Martindale, the Extra Pharmacopoeia. — London: Pharmaceutical Press, 1982. Reynolds W., Topsom R. — S. Org. Chem., 1984, vol. 49, p. 1989. Richards D., Pritchard B. — Clin. Pharmacol. Ther., 1978, vol. 23, p. 253. Richards G., Sackwild V. — Chem. Brit., 1982, vol. 18, p. 635. Richards W. Quantum Pharmacology. — London: Butterworths, 1983. Riddell F. Conformational Analysis of Heterocyclic Compounds. — London: Academic Press, 1980. Rideal E. — Endeavour, 1945, vol. 4, p. 83.
Riegel В., Sherwood L.—i. Amer. Chem. Soc., 1949, vol. 71, p 1129. Rigler N., Bag S., Leyden D. et al. — Anal. Chem., 1965, vol. 37, p. 872.
408" Rinehari 1., Arnold /., Canfield С. — Arner. J. Trop. Med. Hyg., 1976, vol. 25, p. 769.
Ringer S. — J. Physiol., 1883, vol. 4, p. 29.
Riou G., Delain E. — Proc. Natl. Acad. Sci., U.S.A., 1969, vol. 64, p. 618. Ritchie /., Greengard P. — J. Pharmacol., 1961, vol. 133, p. 401. Ritchie /., Greengard P. — Ann. Rev. Pharmacol., 1966, vol. 6, p. 405. Roberts G. —Biochem. J., 1966, vol. 100, 30P.
Roberts G., Feeney /., Birdsall B. et al. — In: Nuclear Magnestic Resonance in
Biology/Ed. R. Dweck1 New York: Academic Press, 1977, p. 95. Roberts J. — In: Structural Chemistry and Molecular Biology ./Eds. A. Rich,
N. Davidson, San Francisco: Freeman, 1968. Roberts /., Pera M. — In: Molecular Aspects of Anit-cancer Drug Action./Eds
S. Neidle1 M. Waring, London: Macmillan Press, 1983. Roberts /., Ray P., Ward-Jardetzky N., Jardetzky О. — Nature, Lond., 1980, vol. 283, p. 870.
Roberts J., Warwick G. —Biochem. Pharmacol., 1961, vol. 6, p. 217. :
Robertson R. The Lifely Membrane. — Cambridge: University Press, 1983. Robins R., Hitchings G. — J. Amer. Chem. Soc., 1955, vol. 77, p. 2256. Robinson R. — Brit. Med. J., 1946, i, p. 945.
Robinson R., Stokes R. Electrolyte Solutions. 2nd edn. — London: Butterworths, 1959.
Rocha e Silva M. (ed.) Histamine and Anti-Histaminics, Handbuch exper. Pharmacol.— Berlin: Springer, 1978, vol. 18. Rodgers M., Powers E. Oxygen and Oxy-Radicals in Chemistry and Biology. —
New York: Academic Press, 1981. Rodgers P., Roberts G. — FEBS Lett., 1973, vol. 36, p. 330. Roe 0. — Pharmacol. Rev., 1955, vol. 7, p. 399.
Roehl W. — Archiv. Schiffs Tropenhyg., 1926b, Bd 30, Beiheft 1, S. 103. Roemer D., Buescher H., Hill R. et at. — Nature, Lond., 1977, vol. 268, p. 547. Rogers H. — Nature, Lond., 1967, vol. 213, p. 31. Rogers H., Mandelstam Л — Biochem. J., 1962, vol. 84, p. 299. Rokos /., Rokos К., Frisius H. et al. — Clin. Chim. Acta, 1980, vol. 105, p. 275. Roques B., Forunie-Zatuski M., Soroca E. et al. — Nature, Lond., 1980, vol. 288, p. 286.
